Raiffeisen Bank International’s bluebird bio BLUE Stock Holding History

Raiffeisen Bank International’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-112	Closed	-$547	–	601
2025 Q1	$547	Hold	112	–	–	﹤0.01%	596
2024 Q4	$972	Buy	+112	New	+$979	﹤0.01%	593

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raiffeisen Bank International's BLUE Position: Q2 2025 in Review

Raiffeisen Bank International sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 112 shares — an estimated $547 sold.

Raiffeisen Bank International first reported a position in BLUE in Q4 2024 and held it in 2 quarters. The position peaked at $972 in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Raiffeisen Bank International reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Raiffeisen Bank International sold 112 bluebird bio shares in Q2 2025, an estimated $547.
Raiffeisen Bank International first reported a position in bluebird bio in Q4 2024 and held it in 2 quarters.
Raiffeisen Bank International's bluebird bio position peaked at $972 in Q4 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Raiffeisen Bank International's 13F filing for Q2 2025, filed 11 Aug 2025.